Bessemer Venture Partners

OvaScience, Inc.

OvaScience is an innovative life science company dedicated to improving the treatment of infertility. OvaScience's first product, AUGMENT, aims to increase the success of in vitro fertilization (IVF). OvaScience's patented technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, allows a woman to use her own cellular energy to revitalize her egg. The company's team of scientists, physicians and advisers are recognized leaders in the field of reproductive medicine. OvaScience was co-founded by Rich Aldrich, Michelle Dipp, and Christoph Westphal, all repeat entrepreneurs with Bessemer.